for the Period Ended 31 July 2024
Profit and loss | |
Balance sheet | |
Additional notes | |
Balance sheet notes | |
Community Interest Report |
for the Period Ended
2024 | 13 months to 31 July 2023 | |
---|---|---|
|
£ |
£ |
Turnover: |
|
|
Cost of sales: |
|
|
Gross profit(or loss): |
|
|
Distribution costs: |
|
|
Administrative expenses: |
(
|
|
Other operating income: |
|
|
Operating profit(or loss): |
|
|
Interest receivable and similar income: |
|
|
Interest payable and similar charges: |
|
|
Profit(or loss) before tax: |
|
|
Tax: |
|
|
Profit(or loss) for the financial year: |
|
|
As at
Notes | 2024 | 13 months to 31 July 2023 | |
---|---|---|---|
|
£ |
£ |
|
Called up share capital not paid: |
|
|
|
Fixed assets | |||
Intangible assets: |
|
|
|
Tangible assets: |
|
|
|
Investments: |
|
|
|
Total fixed assets: |
|
|
|
Current assets | |||
Stocks: | 3 |
|
|
Debtors: |
|
|
|
Cash at bank and in hand: |
|
|
|
Investments: |
|
|
|
Total current assets: |
|
|
|
Prepayments and accrued income: |
|
|
|
Creditors: amounts falling due within one year: |
|
|
|
Net current assets (liabilities): |
|
|
|
Total assets less current liabilities: |
|
|
|
Creditors: amounts falling due after more than one year: |
|
|
|
Provision for liabilities: |
|
|
|
Accruals and deferred income: |
|
|
|
Total net assets (liabilities): |
|
|
|
Capital and reserves | |||
Called up share capital: |
|
|
|
Share premium account: |
|
|
|
Other reserves: |
|
|
|
Profit and loss account: |
|
|
|
Total Shareholders' funds: |
|
|
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 July 2024
Basis of measurement and preparation
Turnover policy
for the Period Ended 31 July 2024
2024 | 13 months to 31 July 2023 | |
---|---|---|
Average number of employees during the period |
|
|
for the Period Ended 31 July 2024
2024 | 13 months to 31 July 2023 | |
---|---|---|
£ | £ | |
Stocks |
|
|
Payments on account |
|
|
Total |
|
|
for the Period Ended 31 July 2024
PatientsCann UK is a patient-led not-for-profit medical cannabis education platform dedicated to advancing the medical cannabis industry through education and engagement. During the financial year August 2023 to July 2024, the organisation's activities have benefited the community in the following ways: - started a nationwide campaign, hosting events at 7 different locations across England and supporting hundreds of local residents better understand access to prescription cannabis in the UK. - published guidance documents alongside reputable organisations and advocates, supporting the rights of patients prescribed cannabis in areas such as driving and employment. - developed online resources for patients prescribed cannabis better navigate their treatment and social life.
No consultation with stakeholders
The total amount paid to directors in respect of qualifying services during the financial year was £2,085.68, comprising £1,680 for remuneration of paid services and £405.68 for additional expenses. No other transactions or arrangements.
No transfer of assets other than for full consideration
This report was approved by the board of directors on
31 March 2025
And signed on behalf of the board by:
Name: Mohammad Wasway
Status: Director